Skip to main content

Allergic Rhinitis News (Page 2)

Are Your Allergies Ready to Head Off to College?

WEDNESDAY, July 5, 2023 – As you stare down your freshman year of college and contemplate living away from home, you’re probably facing a few “firsts”: First roommate who isn’t a sibling; first time ...

Higher Prevalence of Food Allergies Among Racial, Ethnic Minorities

THURSDAY, June 15, 2023 – The prevalence of reported food allergies is higher among U.S. Asian, Hispanic, and non-Hispanic Black individuals compared with non-Hispanic White individuals, and lowest...

Immunotherapy Works Well for Young Children With Peanut Allergy

WEDNESDAY, May 10, 2023 – For children aged 1 to 3 years with peanut allergy, epicutaneous immunotherapy for 12 months is superior for desensitizing children to peanuts, according to a study...

FDA Approves Nasonex 24HR Allergy (mometasone furoate) Nasal Spray for OTC Use

DUBLIN, March 17, 2022 /PRNewswire/ – Perrigo Company plc (NYSE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced that it has received final approval from the...

FDA Approves Ryaltris (mometasone and olopatadine) Nasal Spray for Seasonal Allergic Rhinitis

Mumbai (Maharashtra) [India], January 14, 2022 (ANI/PRNewswire) – Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company announced that its fully owned...

FDA Approves Astepro Allergy (azelastine) Nasal Spray for Over-the-Counter Use

WHIPPANY, N.J.--(BUSINESS WIRE) June 17, 2021-- Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved Astepro Allergy (Azelastine HCI .15%) as an over-the-counter (OTC)...

U.S. FDA Approves ALK's Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use as Immunotherapy for Children and Adolescents With Short Ragweed Pollen-Induced Allergic Rhinitis With or Without Conjunctivitis

ROUND ROCK, Texas, April 19, 2021 /PRNewswire/ – ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the diagnosis and treatment of...

FDA Medwatch Alert: Fluticasone Propionate Nasal Spray by Apotex Corp: Recall - Due to Potential for Small Glass Particles

ISSUE: The Fluticasone Propionate Nasal Spray 50 mcg per spray 120 Metered Sprays has been found to contain small glass particles. The glass particles could block the actuator and impact the...

FDA Approves Odactra for House Dust Mite Allergies

March 1, 2017 – The U.S. Food and Drug Administration today approved Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced...

Sanofi's Xyzal Allergy 24HR Approved for Over-the-Counter Use

BRIDGEWATER, N.J., Feb. 1, 2017 /PRNewswire/ – Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Xyzal Allergy 24HR as an over-the-counter (OTC) treatment for the...

FDA Approves Flonase Sensimist Allergy Relief

WARREN, N.J. 2 August 2016 – GSK Consumer Healthcare announced today that the U.S. Food and Drug Administration (FDA) has approved Flonase® Sensimist™ Allergy Relief (fluticasone furoate, 27.5 mcg sp...

Teva Announces FDA Approval of QNASL for Children with Seasonal and Perennial Allergic Rhinitis

JERUSALEM--(BUSINESS WIRE)--Dec. 19, 2014-- Teva Pharmaceutical Industries Ltd., announced today that the U.S. Food and Drug Administration (FDA) approved QNASL (beclomethasone dipropionate) 40 mcg...

FDA Approves Flonase Allergy Relief for Sale Over-the-Counter in the United States

London UK & Parsippany, US - Thursday 24 July 2014, GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Flonase Allergy Relief...

FDA Approves Sanofi's Nasacort Allergy 24HR for Over-the-Counter Use

Paris, France, October 11, 2013 — Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Nasacort Allergy 24HR nasal spray as an over-the-counter (OTC) treatment for s...

FDA Approves Tris Pharma's New Drug Application for Karbinal ER

MONMOUTH JUNCTION, N.J., April 3, 2013 /PRNewswire/ – Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Nasal Polyps, Allergies

Related drug support groups

prednisone, Benadryl, methylprednisolone, triamcinolone, Singulair, Zyrtec, Claritin, diphenhydramine, Allegra, view more... loratadine, promethazine, Medrol, cetirizine, Phenergan, Claritin-D, dexamethasone, montelukast, fexofenadine, cyproheptadine